EF:BUSINESS-FUTURE-OF-HEALTH

U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign

Leave a Comment / Business / By

Join now for FREE unlimited access to Reuters.com Register Aug 31 (Reuters) – The U.S. Food and Drug Administration on Wednesday cleared Pfizer’s updated COVID-19 booster shots (PFE.N)/BioNTech (22UAy.DE) and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a massive fall vaccination campaign that could begin within days. …

U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign Read More »

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

Leave a Comment / Business / By

Signage is seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Join now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved Bluebird Bio’s (BLUE.O) gene therapy for patients with a rare disease …

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval Read More »

Scroll to Top